Pediapharm (CVE:PDP) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.
Valuation and Earnings
This table compares Pediapharm and Neptune Wellness Solutions' gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Pediapharm | C$11.16 million | 5.95 | C$-16,147,162.00 | C($0.07) | -4.11 |
Neptune Wellness Solutions | C$52.78 million | 4.64 | C$-223,415,550.00 | C($1.35) | -1.10 |
Pediapharm has higher earnings, but lower revenue than Neptune Wellness Solutions. Pediapharm is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and target prices for Pediapharm and Neptune Wellness Solutions, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Pediapharm | 0 | 0 | 0 | 0 | N/A |
Neptune Wellness Solutions | 0 | 0 | 1 | 0 | 3.00 |
Neptune Wellness Solutions has a consensus target price of C$4.63, suggesting a potential upside of 212.50%. Given Neptune Wellness Solutions' higher possible upside, analysts clearly believe Neptune Wellness Solutions is more favorable than Pediapharm.
Profitability
This table compares Pediapharm and Neptune Wellness Solutions' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Pediapharm | N/A | N/A | N/A |
Neptune Wellness Solutions | N/A | N/A | N/A |
Summary
Neptune Wellness Solutions beats Pediapharm on 4 of the 7 factors compared between the two stocks.